Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option
Crossref DOI link: https://doi.org/10.1038/eye.2017.81
Published Online: 2017-05-26
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ashraf, M
Souka, A A R
Text and Data Mining valid from 2017-05-26
Article History
Received: 27 September 2016
Accepted: 26 February 2017
First Online: 26 May 2017
Competing interests
: The authors declare no conflict of interest.